Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 03 08 2018
accepted: 24 12 2018
pubmed: 5 3 2019
medline: 2 5 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

Current proposals for waiting times for a renal transplant after malignant disease may not be appropriate. New data on malignancies in end-stage renal disease and recent diagnostic and therapeutic options should lead us to reconsider our current practice.

Identifiants

pubmed: 30830155
pii: 5369184
doi: 10.1093/ndt/gfz026
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1292-1300

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Auteurs

Bruno Watschinger (B)

Department of Nephrology, Medical University of Vienna, Vienna, Austria.

Klemens Budde (K)

Department of Nephrology, Charité Medical University Berlin, Berlin, Germany.

Marta Crespo (M)

Department of Nephrology, Hospital del Mar, Barcelona, Spain; Institute Mar for Medical Research, Parc de Salut Mar, Barcelona, Spain.

Uwe Heemann (U)

Department of Nephrology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Luuk Hilbrands (L)

Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.

Umberto Maggiore (U)

Department of Nephrology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

Christophe Mariat (C)

Department of Nephrology, Dialysis, and Renal Transplantation, University North Hospital, Saint Etienne, France.

Rainer Oberbauer (R)

Department of Nephrology, Medical University of Vienna, Vienna, Austria.

Gabriel C Oniscu (GC)

Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.

Licia Peruzzi (L)

Pediatric Nephrology Unit, Regina Margherita Children's Hospital, Turin, Italy.

Søren S Sorensen (SS)

Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Ondrej Viklicky (O)

Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Daniel Abramowicz (D)

Department of Nephrology, Antwerp University Hospital, Antwerp University, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH